Clinical Trial Update: Feasibility of Adaptive Radiation Therapy for Human-papilloma Virus-positive Oropharyngeal Cancer Patients on MRIdian Linac [NA]

View source ↗

Summary

A clinical trial evaluating adaptive radiation therapy for HPV-positive oropharyngeal cancer patients using MRIdian Linac has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hpv-positive Oropharyngeal Cancer
• Oropharyngeal Cancer

Snippet

Sponsor: University of Miami | Conditions: Oropharynx Cancer | NA | Status: WITHDRAWN